- Home
- FOR vs ARDX Comparison
FOR vs ARDX Comparison
Compare FOR & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOR
- ARDX
- Stock Information
- Founded
- FOR 2005
- ARDX 2007
- Country
- FOR United States
- ARDX United States
- Employees
- FOR N/A
- ARDX N/A
- Industry
- FOR Real Estate
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- FOR Finance
- ARDX Health Care
- Exchange
- FOR Nasdaq
- ARDX Nasdaq
- Market Cap
- FOR 1.0B
- ARDX 885.2M
- IPO Year
- FOR 2007
- ARDX 2014
- Fundamental
- Price
- FOR $19.53
- ARDX $3.61
- Analyst Decision
- FOR Strong Buy
- ARDX Strong Buy
- Analyst Count
- FOR 3
- ARDX 9
- Target Price
- FOR $30.33
- ARDX $10.17
- AVG Volume (30 Days)
- FOR 151.2K
- ARDX 4.6M
- Earning Date
- FOR 07-22-2025
- ARDX 07-31-2025
- Dividend Yield
- FOR N/A
- ARDX N/A
- EPS Growth
- FOR N/A
- ARDX N/A
- EPS
- FOR 3.29
- ARDX N/A
- Revenue
- FOR $1,471,000,000.00
- ARDX $361,706,000.00
- Revenue This Year
- FOR $3.95
- ARDX $12.01
- Revenue Next Year
- FOR $8.86
- ARDX $34.66
- P/E Ratio
- FOR $5.89
- ARDX N/A
- Revenue Growth
- FOR N/A
- ARDX 127.33
- 52 Week Low
- FOR $18.00
- ARDX $3.21
- 52 Week High
- FOR $37.21
- ARDX $8.06
- Technical
- Relative Strength Index (RSI)
- FOR 44.18
- ARDX 44.31
- Support Level
- FOR $19.32
- ARDX $3.63
- Resistance Level
- FOR $21.23
- ARDX $3.72
- Average True Range (ATR)
- FOR 0.60
- ARDX 0.18
- MACD
- FOR -0.04
- ARDX 0.01
- Stochastic Oscillator
- FOR 22.40
- ARDX 30.23
About FOR Forestar Group Inc
Forestar Group Inc is a residential lot development company with operations across the United States. The core business segment for the company is real estate which generates all of it's revenues. The firm fundamentally acquires entitled real estate and develops it into finished residential lots for sale to homebuilders with a strategic focus on asset turns and efficiency. Single-family residential communities account for the majority of their real estate projects. The company utilizes a lower-risk business model mainly by investing in short duration, phased development projects.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.